Ralph B. Arlinghaus

13.2k total citations · 2 hit papers
250 papers, 10.7k citations indexed

About

Ralph B. Arlinghaus is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Ralph B. Arlinghaus has authored 250 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 109 papers in Molecular Biology, 85 papers in Hematology and 64 papers in Genetics. Recurrent topics in Ralph B. Arlinghaus's work include Chronic Myeloid Leukemia Treatments (81 papers), Chronic Lymphocytic Leukemia Research (57 papers) and Virus-based gene therapy research (47 papers). Ralph B. Arlinghaus is often cited by papers focused on Chronic Myeloid Leukemia Treatments (81 papers), Chronic Lymphocytic Leukemia Research (57 papers) and Virus-based gene therapy research (47 papers). Ralph B. Arlinghaus collaborates with scholars based in United States, Spain and Netherlands. Ralph B. Arlinghaus's co-authors include R.B. Naso, Hui Lin, Moshe Talpaz, L.J. Arcement, Richard S. Schweet, G A Jamjoom, W.L. Karshin, Steven A. Maxwell, Gary E. Gallick and Jerome Polatnick and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Ralph B. Arlinghaus

244 papers receiving 10.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate

2006 903 citations Dunyaporn Trachootham, Yan Zhou et al. Cancer Cell profile →
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571

2002 529 citations Hui Lin, Ralph B. Arlinghaus et al. profile →

Peers

Countries citing papers authored by Ralph B. Arlinghaus

Since Specialization

Citations

This map shows the geographic impact of Ralph B. Arlinghaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph B. Arlinghaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph B. Arlinghaus more than expected).

Fields of papers citing papers by Ralph B. Arlinghaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph B. Arlinghaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph B. Arlinghaus. The network helps show where Ralph B. Arlinghaus may publish in the future.

Co-authorship network of co-authors of Ralph B. Arlinghaus

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph B. Arlinghaus. A scholar is included among the top collaborators of Ralph B. Arlinghaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph B. Arlinghaus. Ralph B. Arlinghaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 2018 ·Advances in Biological Regulation ·William H. Chappell, Saverio Candido, Stephen L. Abrams, Suzanne Russo, Roger Ove, Alberto M. Martelli, Lucio Cocco, Giulia Ramazzotti, Melchiorre Cervello, Giuseppe Montalto, Linda S. Steelman, Xiaohong Leng, Ralph B. Arlinghaus, Massimo Libra, James A. McCubrey	19
2	Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment 2017 ·Cancer Research ·(unknown), Agnieszka Świdnicka‐Siergiejko, (unknown), Myrriah Chavez-Tomar, Gregory B. Lesinski, Tanios Bekaii‐Saab, Matthew R. Farren, Thomas A. Mace, Carl Schmidt, Yan Liu, Defeng Deng, Rosa F. Hwang, Liran Zhou, Todd T. Moore, Deyali Chatterjee, Huamin Wang, Xiaohong Leng, Ralph B. Arlinghaus, Craig D. Logsdon, Zobeida Cruz‐Monserrate	114
3	Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia 2016 ·Molecular Cancer Therapeutics ·Chaofeng Mu, Xiaoyan Wu, Helen Ma, Wenjing Tao, Guodong Zhang, Xiaojun Xia, Jianliang Shen, Junhua Mai, Tong Sun, Xiaoping Sun, Ralph B. Arlinghaus, Haifa Shen	5
4	Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis 2009 ·Cancer Research ·Xiaohong Leng, Tian Ding, Hui Lin, Yan Wang, Limei Hu, Jianhua Hu, Barry W. Feig, Wei Zhang, Lajos Pusztai, W. Fraser Symmans, Yun Wu, Ralph B. Arlinghaus	148
5	Kinase domain mutants of Bcr enhance Bcr-Abl oncogenic effects 2007 ·Oncogene ·(unknown), Hui‐Kuan Lin, Tong Sun, (unknown), Ralph B. Arlinghaus	4
6	Janus Kinase 2: A Critical Target in Chronic Myelogenous Leukemia 2006 ·Cancer Research ·Ajoy K. Samanta, Hui Lin, Tong Sun, Hagop M. Kantarjian, Ralph B. Arlinghaus	123
7	Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate breakdown → 2006 ·Cancer Cell ·Dunyaporn Trachootham, Yan Zhou, Hui Zhang, Yusuke Demizu, Chen Zhao, Hélène Pelicano, Paul J. Chiao, Geetha Achanta, Ralph B. Arlinghaus, Jinsong Liu, Peng Huang	903
8	Bcr-Abl expression induces redox imbalance with a preferential increase in hydrogen peroxide 2006 ·Cancer Research ·Hui Zhang, Geetha Achanta, Feng Li, Ralph B. Arlinghaus, Peng Huang	1
9	The c-Myc Oncoprotein Interacts with Bcr 2003 ·Current Biology ·Gwendolyn M. Mahon, Yan Wang, (unknown), (unknown), Li Cheng, Tong Sun, Ralph B. Arlinghaus, Ian P. Whitehead	20
10	Phosphorylation on Tyrosine-15 of p34Cdc2 by ErbB2 Inhibits p34Cdc2 Activation and Is Involved in Resistance to Taxol-Induced Apoptosis 2002 ·Molecular Cell ·Ming Tan, Jing Tong, Keng‐Hsueh Lan, Christopher L. Neal, Ping Li, Sangkyou Lee, Dexing Fang, Yoichi Nagata, Jiaxin Liu, Ralph B. Arlinghaus, Mien‐Chie Hung, Dihua Yu	108
11	The Involvement of Bcr in Leukemias with the Philadelphia Chromosome 1998 ·Critical Reviews™ in Oncogenesis ·Ralph B. Arlinghaus	16
12	Inhibition of v-Mos Kinase Activity by Protein Kinase A 1996 ·Molecular and Cellular Biology ·Yandan Yang, Christine Herrmann, Ralph B. Arlinghaus, Balraj Singh	15
13	Studies on in Vivo Induction of Cytotoxic T Lymphocyte Responses by Synthetic Peptides from E6 and E7 Oncoproteins of Human Papillomavirus Type 16 1995 ·Viral Immunology ·(unknown), Guillermo Tortolero‐Luna, Pramod N. Nehete, Ralph B. Arlinghaus, Mote Mitchell, K. Jagannadha Sastry	28
14	Cross-Reactive Cytotoxic T Lymphocytes Induced by V3 Loop Synthetic Peptides from Different Strains of Human Immunodeficiency Virus Type 1 1995 ·Virology ·(unknown), Pramod N. Nehete, Ralph B. Arlinghaus, K. Jagannadha Sastry	19
15	Use of Helper T Cell-Inducing Peptides from Conserved Regions in HIV-1 env in a Noncovalent Mixture with a CTL-Inducing V3-Loop Peptide for in Vivo Induction of Long-Lasting Systemic CTL Response 1994 ·Viral Immunology ·Pramod N. Nehete, Ralph B. Arlinghaus, K. Jagannadha Sastry	6
16	Induction of Human Immunodeficiency Virus-Specific T Cell Responses in Rhesus Monkeys by Synthetic Peptides from gp160 1993 ·AIDS Research and Human Retroviruses ·Pramod N. Nehete, William C. Satterfield, (unknown), Ralph B. Arlinghaus, K. Jagannadha Sastry	13
17	Membrane-permeable dideoxyuridine 5'-monophosphate analogue inhibits human immunodeficiency virus infection. 1992 ·Molecular Pharmacology ·K. Jagannadha Sastry, Pramod N. Nehete, Saeed R. Khan, Billie Nowak, William Plunkett, Ralph B. Arlinghaus, David Farquhar	58
18	Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells 1989 ·Virology ·Balraj Singh, Ralph B. Arlinghaus	30
19	p37(mos) encoded by the HT-1 strain of Moloney murine sarcoma virus has an associated protein kinase activity 1988 ·Oncogene ·Balraj Singh, Norbert K. Herzog, (unknown), Ralph B. Arlinghaus	8
20	Proteins of Rauscher murine leukemia virus: Resolution of a 70,000-dalton, nonglycosylated polypeptide containing p30 peptide sequences 1975 ·Virology ·G A Jamjoom, W.L. Karshin, R.B. Naso, L.J. Arcement, Ralph B. Arlinghaus	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact